BSX BOSTON SCIENTIFIC CORP
16 people · 128 trades · ExecutiveHouseSenate
Who trades it
Share of estimated traded dollars. Reports give a band ($1K–$15K, $15K–$50K, …), not the exact amount; the estimate is the middle of each band. Anyone above 5% is named; the rest are grouped.
$42.60
-0.63 (-1.46%) today
Click an arrow to show only that person.
Loading the live price…
By month of the trade. Buys above the line, sells below.
Who owns it now
estimated from their latest financial disclosure and trades since, at today's price| Who | Buys | Sells | Bought (est.) | Sold (est.) | Traded (est.) | Holding | Shares (from trades) | Value now | P/L | P/L % | Lag | Latest trade | Value (disclosed) | Range | Shares (disclosed) | Owner | Basis | Evidence | Why | Party | Role | Chance it's luck | Trades (all stocks) | Buys / sells (all stocks) | Est. volume | Est. P/L (all stocks) | Assets (est.) | Net worth (est.) | Return 1Y | S&P 1Y | Return all | S&P all | Return 1Y (whole) | S&P 1Y (whole) | Lag (all stocks) | Reports | Last trade (any stock) | Latest disclosure | Added | After | Buys tested | Months | Lead vs S&P 500 | Lead vs Nasdaq-100 | Their buys: 1Y | S&P 500: 1Y | Their buys: since first | S&P 500: since first | Random picks vs Nasdaq | Score (SDs above random picks) | Chance it's luck (test) | After testing everyone | Result | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
11 | 11 | $1.5M | $1.6M | $3.1M | Held | 8,675 | $370K | −$118K | -7.8% | 66d | Jul 27, 2026 | $370K | $242K – $497K | 8,675 | Family / joint | report + trades | Dec 31, 2025 | — | — | Executive President | not ahead | 5,941 | $786M | $10.3M | $2.5B | $2.1B | +9.2% | +18.6% | +16.0% | +32.3% | +12.1% | +18.0% | 64d | 25 | Jul 31, 2026 | Sep 22, 2026 | — | 1 month | 1948 | 12 | +0.1% | -0.6% | +34.7% | +21.4% | +7.0% | +9.8% | -0.7% | 0.43 | not ahead of both | 100% | No sign | ||
Michael T. McCaul
R |
2 | 14 | $40.5K | $828K | $869K | Held | 5,685 | $242K | $240K | +18.3% | 21d | Mar 27, 2026 | $242K | $185K – $299K | 5,685 | — | trades only | Nov 18, 2019 | — | R | House TX10 | not ahead | 2,626 | $179M | $165M | ~$236M | — | +13.2% | +15.2% | +75.0% | +100.1% | — | — | 27d | 154 | Jun 30, 2026 | Jul 08, 2026 | — | 1 month | 406 | 33 | -0.2% | -0.9% | +17.7% | +22.5% | +28.6% | +33.8% | -0.9% | 0.10 | not ahead of both | 100% | No sign | ||
Kevin Hern
R |
— | 7 | — | $239K | $239K | Held | 611 | $26K | $33.5K | +14.5% | 25d | Sep 09, 2026 | $201K | $134K – $268K | 4,719 | joint | report | Dec 31, 2025 | — | R | House OK01 | 1 in 3 | 364 | $18.4M | $7.1M | $112M | $112M | +8.3% | +14.2% | +41.9% | +100.8% | +8.6% | +14.5% | 22d | 92 | Sep 15, 2026 | Sep 28, 2026 | — | 1 month | 55 | 13 | +0.5% | +0.7% | +14.8% | +19.4% | +40.3% | +54.8% | +0.4% | 0.48 | 1 in 3 | 100% | No sign | ||
Gilbert Ray Cisneros, Jr.
D |
9 | 9 | $72K | $72K | $144K | Held | 886 | $37.8K | $3.7K | +4.6% | 22d | Aug 18, 2026 | $113K | $49K – $176K | 2,644 | Self | report + trades | Dec 31, 2025 | — | D | House CA31 | not ahead | 1,532 | $16.7M | $6.8M | $88.7M | $70.7M | +11.4% | +15.6% | +75.4% | +93.7% | +16.4% | +16.4% | 25d | 45 | Aug 28, 2026 | Sep 10, 2026 | — | 1 month | 764 | 20 | +0.4% | +0.2% | +26.8% | +22.8% | +12.1% | +15.8% | +0.5% | -0.77 | 1 in 1 | 100% | No sign | ||
| JZ Joel Zinberg | — | — | — | — | — | — | — | — | — | — | — | — | $33.5K | $22.3K – $44.7K | 787 | Spouse | report | Dec 31, 2025 | — | — | Executive | 1 in 4 | 30 | $619K | $40.2K | $43.6M | $43.6M | +10.4% | +15.8% | +12.9% | +18.6% | +12.2% | +14.8% | 98d | 12 | Mar 12, 2026 | Apr 01, 2026 | — | 1 month | 18 | 8 | +0.6% | +0.5% | +16.9% | +18.5% | +12.5% | +16.3% | -0.3% | 0.64 | 1 in 4 | 100% | No sign | ||
Kevin Hern
R |
— | 7 | — | $239K | $239K | Held | 611 | $26K | $33.5K | +14.5% | 25d | Sep 09, 2026 | $29K | $13.4K – $44.7K | 682 | child | report + trades | Dec 31, 2025 | — | R | House OK01 | 1 in 3 | 364 | $18.4M | $7.1M | $112M | $112M | +8.3% | +14.2% | +41.9% | +100.8% | +8.6% | +14.5% | 22d | 92 | Sep 15, 2026 | Sep 28, 2026 | — | 1 month | 55 | 13 | +0.5% | +0.7% | +14.8% | +19.4% | +40.3% | +54.8% | +0.4% | 0.48 | 1 in 3 | 100% | No sign | ||
Ro Khanna
D |
17 | 15 | $161K | $218K | $379K | Held | 517 | $22K | $14K | +8.3% | 27d | Aug 10, 2026 | $22K | $2.8K – $41.3K | 517 | — | trades only | Nov 03, 2022 | Picked by you | D | House CA17 | not ahead | 12,066 | $377M | $18.2M | ~$119M | — | +18.1% | +28.5% | +69.8% | +109.4% | — | — | 24d | 122 | Aug 31, 2026 | Sep 04, 2026 | Sep 26, 2026 | 1 month | 3874 | 35 | -0.3% | -0.7% | +15.4% | +21.3% | +25.5% | +33.1% | -0.6% | -0.62 | not ahead of both | 100% | No sign | ||
| LM Lucy Mcbath | — | — | — | — | — | — | — | — | — | — | — | — | $18.1K | $7.1K – $29K | 425 | Spouse | report | Dec 31, 2025 | — | D | House GA07 | no recent buys | — | — | — | $7.8M | $7.7M | — | — | — | — | +10.8% | +17.1% | — | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
Julie Johnson
D |
— | — | — | — | — | — | — | — | — | — | — | — | $14.5K | $6.7K – $22.3K | 341 | joint | report | Dec 31, 2025 | — | D | House TX32 | 1 in 4 | 587 | $4.9M | $24.5K | $37.2M | $32.7M | +6.7% | +13.6% | +21.2% | +31.5% | +8.5% | +17.1% | 28d | 15 | May 12, 2026 | Aug 05, 2026 | — | 3 months | 101 | 12 | +0.1% | +0.5% | +19.7% | +17.6% | +16.5% | +25.9% | -0.6% | 0.62 | 1 in 4 | 100% | No sign | ||
Robert P. Bresnahan, Jr.
R |
— | — | — | — | — | — | — | — | — | — | — | — | $14.5K | $6.7K – $22.3K | 341 | Self | report | Dec 31, 2025 | — | R | House PA08 | not ahead | 611 | $6.3M | $874K | $40.2M | $30M | +24.0% | +15.1% | +51.2% | +43.5% | +13.2% | +16.5% | 30d | 22 | Dec 11, 2025 | Dec 19, 2025 | — | 1 month | 204 | 6 | +0.7% | -0.3% | +22.4% | +27.2% | +44.8% | +41.5% | -0.8% | 0.68 | not ahead of both | 100% | No sign | ||
|
|
— | — | — | — | — | — | — | — | — | — | — | — | $14.1K | $6.5K – $21.7K | 331 | Family / joint | report | Jan 16, 2025 | — | — | Executive Director | ~1 in 8 | 95 | $61.7M | −$253K | $721M | $701M | -22.7% | +15.1% | -8.4% | +22.7% | -6.6% | +15.3% | 35d | 16 | Aug 07, 2026 | Sep 30, 2026 | — | 3 months rough | 1 | 1 | +17.7% | +16.6% | -7.8% | +19.5% | -4.5% | +24.2% | -3.6% | 1.18 | ~1 in 8 | 100% | Rough (few buys) | ||
| WC Walter Clayton | — | — | — | — | — | — | — | — | — | — | — | — | $7.3K | $909 – $13.6K | 171 | Family / joint | report | Jun 12, 2026 | — | — | Executive Director | no recent buys | — | — | — | $81.8M | $78M | — | — | — | — | -1.5% | +3.9% | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
|
|
1 | — | $8K | — | $8K | Held | 116 | $4.9K | −$3.1K | -38.4% | 116d | Mar 27, 2026 | $4.9K | $616 – $9.2K | 116 | — | trades only | Mar 27, 2026 | — | R | Senate OK | not ahead | 707 | $25.1M | $919K | $179M | $179M | +19.8% | +21.7% | +19.8% | +21.7% | +14.6% | +16.0% | 113d | 3 | Aug 20, 2026 | Sep 17, 2026 | — | 1 month rough | 350 | 1 | -4.1% | -9.1% | — | — | +15.8% | +22.1% | -9.5% | 0.56 | not ahead of both | 100% | Rough (few buys) | ||
| MC Michael Conaway | — | — | — | — | — | — | — | — | — | — | — | — | $4.8K | $606 – $9.1K | 114 | — | trades only | Mar 18, 2015 | — | R | House TX11 | no recent buys | — | — | $6.1M | ~$10.2M | — | +14.3% | +15.1% | +77.4% | +98.5% | — | — | — | 88 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
Michael A. Rulli
R |
— | — | — | — | — | — | — | — | — | — | — | — | $3.6K | $447 – $6.7K | 84 | Self | report | Dec 31, 2025 | — | R | House OH06 | not ahead | 35 | $347K | $4.2K | $27M | $26.7M | -8.2% | +16.0% | +13.0% | +32.2% | -2.7% | +11.9% | 210d | 5 | Aug 24, 2026 | Sep 02, 2026 | — | 1 month | 14 | 10 | -6.6% | -5.0% | +23.4% | +22.4% | +11.4% | +12.9% | +1.1% | -1.76 | not ahead of both | 100% | No sign | ||
John J. McGuire III
R |
— | — | — | — | — | — | — | — | — | — | — | — | $3.6K | $447 – $6.7K | 84 | Spouse | report | Dec 31, 2025 | — | R | House VA05 | not ahead | 22 | $176K | −$569 | $1.7M | $925K | +7.9% | +15.7% | -1.5% | +31.7% | +17.0% | +17.1% | 20d | 10 | Aug 18, 2026 | Sep 02, 2026 | — | 1 month | 13 | 8 | -8.4% | -9.2% | -37.6% | +26.3% | -0.6% | +15.5% | -1.2% | -1.81 | not ahead of both | 100% | No sign | ||
| LM Lucy Mcbath | — | — | — | — | — | — | — | — | — | — | — | — | $3.6K | $447 – $6.7K | 84 | Self | report | Dec 31, 2025 | — | D | House GA07 | no recent buys | — | — | — | $7.8M | $7.7M | — | — | — | — | +10.8% | +17.1% | — | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
| JF Jeffrey Freeland | — | — | — | — | — | — | — | — | — | — | — | — | $3.6K | $447 – $6.7K | 84 | Family / joint | report | Dec 31, 2025 | — | — | Executive | no recent buys | — | — | — | $12.6M | $12.6M | — | — | — | — | +12.7% | +17.2% | — | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
| TH Thomas Homan | — | — | — | — | — | — | — | — | — | — | — | — | $3.6K | $447 – $6.7K | 84 | Self | report | Dec 31, 2025 | — | — | Executive | no recent buys | — | — | — | $7.3M | $7.3M | — | — | — | — | +4.7% | +15.0% | — | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
| HH Harriet Hageman | — | — | — | — | — | — | — | — | — | — | — | — | $3.6K | $447 – $6.7K | 84 | Spouse | report | Dec 31, 2025 | — | R | House WY00 | no recent buys | — | — | — | $4.7M | $4.3M | — | — | — | — | +5.9% | +16.6% | — | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
| PW Paige Willey | — | — | — | — | — | — | — | — | — | — | — | — | $3.3K | $414 – $6.2K | 78 | Self | report | May 13, 2025 | — | — | Executive | no recent buys | — | — | — | $1.6M | $1.6M | — | — | — | — | +8.4% | +15.1% | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
| EL Eric Lander | — | — | — | — | — | — | — | — | — | — | — | — | $501 | $0 – $1K | 12 | Family / joint | report | Feb 18, 2022 | — | — | Executive Director | no recent buys | — | — | — | $88.1M | $87.9M | — | — | — | — | +0.2% | +15.1% | — | 6 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
| AL Alan Lowenthal | — | — | — | — | — | — | — | — | — | — | — | — | $403 | $0 – $805 | 9 | joint | report | Apr 19, 2023 | — | D | House CA47 | no recent buys | — | — | $2.6M | $3.8M | $3.5M | -4.1% | +15.1% | +56.3% | +98.5% | -3.6% | +15.1% | — | 527 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
| AL Alan Lowenthal | — | — | — | — | — | — | — | — | — | — | — | — | $403 | $0 – $805 | 9 | Spouse | report | Apr 19, 2023 | — | D | House CA47 | no recent buys | — | — | $2.6M | $3.8M | $3.5M | -4.1% | +15.1% | +56.3% | +98.5% | -3.6% | +15.1% | — | 527 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
Jefferson Shreve
R |
— | 1 | — | $32.5K | $32.5K | Bought before 2014 | — | — | — | — | 41d | May 12, 2025 | $223 | $0 – $447 | 5 | Self | report | Dec 31, 2025 | — | R | House IN06 | not ahead | 557 | $29.4M | $589K | $737M | $737M | +10.0% | +15.1% | +97.1% | +150.6% | +7.6% | +17.1% | 31d | 13 | May 12, 2025 | Jun 22, 2025 | — | 1 month rough | 182 | 4 | +0.3% | -0.9% | +30.8% | +26.7% | +45.9% | +42.5% | -1.5% | 0.82 | not ahead of both | 100% | Rough (few buys) | ||
|
|
— | 1 | — | $8K | $8K | Bought before 2014 | — | — | — | — | 50d | Mar 25, 2025 | $223 | $0 – $447 | 5 | Family / joint | report | Dec 31, 2025 | — | — | Executive Deputy Secretary | no recent buys | 63 | $745K | — | $23M | $23M | — | — | — | — | +6.5% | +15.8% | 50d | 3 | Mar 25, 2025 | May 14, 2025 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | ||
|
|
— | — | — | — | — | — | — | — | — | — | — | — | $203 | $0 – $406 | 5 | Family / joint | report | Nov 13, 2025 | — | — | Executive Administrator | not ahead | 137 | $166M | −$33.1M | $585M | $280M | -30.7% | +11.8% | -30.7% | +11.8% | -40.6% | +14.9% | 72d | 3 | May 12, 2026 | Jun 18, 2026 | — | 1 month rough | 4 | 3 | -8.1% | -8.0% | — | — | -16.2% | +10.2% | -1.5% | -1.28 | not ahead of both | 100% | Rough (few buys) |
Traders
click a trader for their trades in BSX| Trader | Buys | Sells | Bought (est.) | Sold (est.) | Traded (est.) | Holding | Shares (from trades) | Value now | P/L | P/L % | Lag | Latest trade | Value (disclosed) | Range | Shares (disclosed) | Owner | Basis | Evidence | Why | Party | Role | Chance it's luck | Trades (all stocks) | Buys / sells (all stocks) | Est. volume | Est. P/L (all stocks) | Assets (est.) | Net worth (est.) | Return 1Y | S&P 1Y | Return all | S&P all | Return 1Y (whole) | S&P 1Y (whole) | Lag (all stocks) | Reports | Last trade (any stock) | Latest disclosure | Added | After | Buys tested | Months | Lead vs S&P 500 | Lead vs Nasdaq-100 | Their buys: 1Y | S&P 500: 1Y | Their buys: since first | S&P 500: since first | Random picks vs Nasdaq | Score (SDs above random picks) | Chance it's luck (test) | After testing everyone | Result | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
11 | 11 | $1.5M | $1.6M | $3.1M | Held | 8,675 | $370K | −$118K | -7.8% | 66d | Jul 27, 2026 | $370K | $242K – $497K | 8,675 | Family / joint | report + trades | Dec 31, 2025 | — | — | Executive President | not ahead | 5,941 | $786M | $10.3M | $2.5B | $2.1B | +9.2% | +18.6% | +16.0% | +32.3% | +12.1% | +18.0% | 64d | 25 | Jul 31, 2026 | Sep 22, 2026 | — | 1 month | 1948 | 12 | +0.1% | -0.6% | +34.7% | +21.4% | +7.0% | +9.8% | -0.7% | 0.43 | not ahead of both | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Michael T. McCaul
R |
2 | 14 | $40.5K | $828K | $869K | Held | 5,685 | $242K | $240K | +18.3% | 21d | Mar 27, 2026 | $242K | $185K – $299K | 5,685 | — | trades only | Nov 18, 2019 | — | R | House TX10 | not ahead | 2,626 | $179M | $165M | ~$236M | — | +13.2% | +15.2% | +75.0% | +100.1% | — | — | 27d | 154 | Jun 30, 2026 | Jul 08, 2026 | — | 1 month | 406 | 33 | -0.2% | -0.9% | +17.7% | +22.5% | +28.6% | +33.8% | -0.9% | 0.10 | not ahead of both | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ro Khanna
D |
17 | 15 | $161K | $218K | $379K | Held | 517 | $22K | $14K | +8.3% | 27d | Aug 10, 2026 | $22K | $2.8K – $41.3K | 517 | — | trades only | Nov 03, 2022 | Picked by you | D | House CA17 | not ahead | 12,066 | $377M | $18.2M | ~$119M | — | +18.1% | +28.5% | +69.8% | +109.4% | — | — | 24d | 122 | Aug 31, 2026 | Sep 04, 2026 | Sep 26, 2026 | 1 month | 3874 | 35 | -0.3% | -0.7% | +15.4% | +21.3% | +25.5% | +33.1% | -0.6% | -0.62 | not ahead of both | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kevin Hern
R |
— | 7 | — | $239K | $239K | Held | 611 | $26K | $33.5K | +14.5% | 25d | Sep 09, 2026 | $29K | $13.4K – $44.7K | 682 | child | report + trades | Dec 31, 2025 | — | R | House OK01 | 1 in 3 | 364 | $18.4M | $7.1M | $112M | $112M | +8.3% | +14.2% | +41.9% | +100.8% | +8.6% | +14.5% | 22d | 92 | Sep 15, 2026 | Sep 28, 2026 | — | 1 month | 55 | 13 | +0.5% | +0.7% | +14.8% | +19.4% | +40.3% | +54.8% | +0.4% | 0.48 | 1 in 3 | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Markwayne Mullin
R |
3 | 1 | $73K | $75K | $148K | Sold out | — | — | −$11.2K | -15.3% | 29d | May 18, 2026 | — | — | — | — | — | — | — | R | Executive House Senate OK02 | 1 in 111 | 483 | $24.8M | $2.4M | $105M | $77.5M | +16.0% | +14.2% | +83.2% | +79.3% | +11.0% | +15.9% | 29d | 51 | Jun 10, 2026 | Jul 25, 2026 | — | 1 year | 127 | 13 | +6.1% | +3.6% | +33.4% | +27.1% | +57.6% | +45.8% | -7.7% | 2.74 | 1 in 111 | 76% | Worth watching, not proven | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gilbert Ray Cisneros, Jr.
D |
9 | 9 | $72K | $72K | $144K | Held | 886 | $37.8K | $3.7K | +4.6% | 22d | Aug 18, 2026 | $113K | $49K – $176K | 2,644 | Self | report + trades | Dec 31, 2025 | — | D | House CA31 | not ahead | 1,532 | $16.7M | $6.8M | $88.7M | $70.7M | +11.4% | +15.6% | +75.4% | +93.7% | +16.4% | +16.4% | 25d | 45 | Aug 28, 2026 | Sep 10, 2026 | — | 1 month | 764 | 20 | +0.4% | +0.2% | +26.8% | +22.8% | +12.1% | +15.8% | +0.5% | -0.77 | 1 in 1 | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lois Frankel
D |
1 | 6 | $8K | $48K | $56K | Held | 208 | $8.9K | $16.9K | +42.2% | 30d | Sep 08, 2023 | — | — | — | — | — | — | — | D | House FL22 | no recent buys | 219 | $1.9M | $1.7M | $2.8M | $1.9M | +6.2% | +15.1% | +35.9% | +101.1% | +4.7% | +15.1% | 32d | 123 | Sep 08, 2023 | May 14, 2024 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lisa C. McClain
R |
2 | 3 | $16K | $24K | $40K | Held | 0 | $5 | $1.4K | +8.5% | 22d | Oct 31, 2025 | — | — | — | — | — | — | — | R | House MI09 | not ahead | 1,407 | $12.8M | $1.2M | $7.3M | $7.2M | +21.7% | +15.9% | +145.1% | +54.4% | +12.1% | +15.8% | 34d | 12 | Feb 06, 2026 | Mar 04, 2026 | — | 1 month | 666 | 14 | -1.2% | -1.1% | +20.4% | +21.8% | +23.1% | +24.9% | -0.3% | -2.48 | not ahead of both | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Jefferson Shreve
R |
— | 1 | — | $32.5K | $32.5K | Bought before 2014 | — | — | — | — | 41d | May 12, 2025 | $223 | $0 – $447 | 5 | Self | report | Dec 31, 2025 | — | R | House IN06 | not ahead | 557 | $29.4M | $589K | $737M | $737M | +10.0% | +15.1% | +97.1% | +150.6% | +7.6% | +17.1% | 31d | 13 | May 12, 2025 | Jun 22, 2025 | — | 1 month rough | 182 | 4 | +0.3% | -0.9% | +30.8% | +26.7% | +45.9% | +42.5% | -1.5% | 0.82 | not ahead of both | 100% | Rough (few buys) | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
John Boozman
R |
1 | 2 | $8K | $16K | $24K | Sold out | — | — | −$879 | -11.0% | 27d | Jun 04, 2026 | — | — | — | — | — | — | — | R | Senate AR | not ahead | 539 | $5.4M | $848K | $4.3M | $3.6M | +7.9% | +15.3% | +38.6% | +96.4% | +7.2% | +15.2% | 27d | 143 | Aug 27, 2026 | Sep 11, 2026 | — | 1 month | 196 | 30 | -0.6% | -0.7% | +17.7% | +22.5% | +17.3% | +26.2% | -0.0% | -1.34 | not ahead of both | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
John R. Curtis
R |
— | 3 | — | $24K | $24K | Sold out | — | — | $6.4K | +40.3% | 14d | Dec 04, 2023 | — | — | — | — | — | — | — | R | House Senate UT03 | no recent buys | 106 | $922K | $720K | $18.3M | $12.3M | +25.5% | +15.1% | +129.5% | +104.7% | +12.4% | +15.1% | 11d | 37 | Dec 04, 2023 | Dec 15, 2023 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bruce Westerman
R |
1 | 1 | $8K | $8K | $16K | Sold out | — | — | −$861 | -10.8% | 32d | Apr 21, 2025 | — | — | — | — | — | — | — | R | House AR04 | ~1 in 24 | 213 | $1.9M | −$14.4K | $1.2M | $1.2M | +30.0% | +15.1% | -7.2% | -19.9% | +13.4% | +14.9% | 27d | 5 | Apr 21, 2025 | May 12, 2025 | — | 1 year rough | 81 | 2 | +7.1% | +2.0% | +27.3% | +20.2% | +35.0% | +36.3% | -8.5% | 1.95 | ~1 in 24 | 100% | Rough (few buys) | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Val T. Hoyle
D |
1 | 1 | $8K | $8K | $16K | Held | 13 | $542 | $542 | +6.8% | 168d | Sep 23, 2025 | — | — | — | — | — | — | — | D | House OR04 | not ahead | 393 | $3.4M | $170K | $1.1M | $924K | +17.0% | +15.1% | +26.7% | +36.3% | +14.0% | +16.1% | 98d | 6 | Sep 23, 2025 | May 15, 2026 | — | 1 month | 179 | 12 | +0.2% | +1.2% | +11.6% | +19.7% | +29.6% | +34.0% | +2.6% | -2.00 | 1 in 1 | 100% | No sign | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lori Chavez-DeRemer
R |
— | 1 | — | $8K | $8K | Bought before 2014 | — | — | — | — | 134d | Apr 28, 2025 | — | — | — | — | — | — | — | R | Executive House OR05 | no recent buys | 96 | $891K | — | $16.3M | $12.7M | — | — | — | — | +11.4% | +18.6% | 134d | 4 | Apr 28, 2025 | Sep 09, 2025 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
1 | — | $8K | — | $8K | Held | 116 | $4.9K | −$3.1K | -38.4% | 116d | Mar 27, 2026 | $4.9K | $616 – $9.2K | 116 | — | trades only | Mar 27, 2026 | — | R | Senate OK | not ahead | 707 | $25.1M | $919K | $179M | $179M | +19.8% | +21.7% | +19.8% | +21.7% | +14.6% | +16.0% | 113d | 3 | Aug 20, 2026 | Sep 17, 2026 | — | 1 month rough | 350 | 1 | -4.1% | -9.1% | — | — | +15.8% | +22.1% | -9.5% | 0.56 | not ahead of both | 100% | Rough (few buys) | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
— | 1 | — | $8K | $8K | Bought before 2014 | — | — | — | — | 50d | Mar 25, 2025 | $223 | $0 – $447 | 5 | Family / joint | report | Dec 31, 2025 | — | — | Executive Deputy Secretary | no recent buys | 63 | $745K | — | $23M | $23M | — | — | — | — | +6.5% | +15.8% | 50d | 3 | Mar 25, 2025 | May 14, 2025 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | not tested | |||||||
Loading… | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Estimates: each trade at the middle of its amount band and that day's close; held shares at the live price.
Trades
128 trades
| Disclosed | Who | Chance it's luck | Ticker | Type | Amount | Traded | Lag | Price at trade | Price now | Since trade | After report | Before report | S&P since trade | Per year | Price at report | Est. shares | Worth now | $ since trade | Sale P/L | Held | Shares after | Position after | Next 30 days | Owner | Asset as written | Fund | Sector | Read by |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 |
Kevin Hern
R
ⓘ
|
1 in 3 | BSX | Sell ½ | $50K–$100K | Sep 04, 2026 | 24d | $47.80 | $42.60 | -10.9% | -3.4% | -7.7% | -0.1% | — | $44.11 | 1,569 | $66.8K | $8.2K | $7.2K+10.6% | 1933d | 2,279 | $109K | — | joint | Boston Scientific Corporation Common Stock (BSX) [ST] | — | Health Care | textlayer |
| ||||||||||||||||||||||||||||
| Sep 28, 2026 |
Kevin Hern
R
ⓘ
|
1 in 3 | BSX | Sell | $1K–$15K | Sep 03, 2026 | 25d | $46.95 | $42.60 | -9.3% | -3.4% | -6.0% | -0.5% | — | $44.11 | 170 | $7.3K | $741 | $633+8.6% | 1932d | 4,189 | $197K | — | dependent | Boston Scientific Corporation Common Stock (BSX) [ST] | — | Health Care | textlayer |
| ||||||||||||||||||||||||||||
| Sep 28, 2026 |
Kevin Hern
R
ⓘ
|
1 in 3 | BSX | Sell | $1K–$15K | Sep 03, 2026 | 25d | $46.95 | $42.60 | -9.3% | -3.4% | -6.0% | -0.5% | — | $44.11 | 170 | $7.3K | $741 | $633+8.6% | 1932d | 4,019 | $189K | — | dependent | Boston Scientific Corporation Common Stock (BSX) [ST] | — | Health Care | textlayer |
| ||||||||||||||||||||||||||||
| Sep 28, 2026 |
Kevin Hern
R
ⓘ
|
1 in 3 | BSX | Sell | $1K–$15K | Sep 03, 2026 | 25d | $46.95 | $42.60 | -9.3% | -3.4% | -6.0% | -0.5% | — | $44.11 | 170 | $7.3K | $741 | $633+8.6% | 1932d | 3,848 | $181K | — | dependent | Boston Scientific Corporation Common Stock (BSX) [ST] | — | Health Care | textlayer |
| ||||||||||||||||||||||||||||
| Sep 28, 2026 |
Kevin Hern
R
ⓘ
|
1 in 3 | BSX | Sell | $50K–$100K | Sep 09, 2026 | 19d | $44.96 | $42.60 | -5.2% | -3.4% | -1.9% | +0.9% | — | $44.11 | 1,668 | $71.1K | $3.9K | $2.9K+4.0% | 1938d | 611 | $27.5K | — | joint | Boston Scientific Corporation Common Stock (BSX) [ST] | — | Health Care | textlayer |
| ||||||||||||||||||||||||||||
| Sep 28, 2026 |
Kevin Hern
R
ⓘ
|
1 in 3 | BSX | Sell | $15K–$50K | Aug 31, 2026 | 28d | $48.30 | $42.60 | -11.8% | -3.4% | -8.7% | +0.3% | — | $44.11 | 673 | $28.7K | $3.8K | $3.4K+11.7% | 1929d | 4,360 | $211K | — | joint | Boston Scientific Corporation Common Stock (BSX) [ST] | — | Health Care | textlayer |
| ||||||||||||||||||||||||||||
| Sep 22, 2026 |
|
not ahead | BSX | Sell | $15K–$50K | Jul 17, 2026 | 67d | $44.03 | $42.60 | -3.2% | -5.2% | +2.0% | +3.5% | — | $44.92 | 738 | $31.4K | $1.1K | — | — | 0 | — | — | — | Boston Scientific Coro | — | Health Care | textlayer · 80% |
| ||||||||||||||||||||||||||||
| Sep 22, 2026 |
|
not ahead | BSX | Buy | $50K–$100K | Jul 27, 2026 | 57d | $45.51 | $42.60 | -6.4% | -5.2% | -1.3% | +4.1% | — | $44.92 | 1,648 | $70.2K | −$4.8K | — | — | 8,675 | $395K | +5.8% | — | BOSTON SCIENTIFIC CORP | — | Health Care | textlayer · 80% |
| ||||||||||||||||||||||||||||
| Sep 22, 2026 |
|
not ahead | BSX | Buy | $1K–$15K | Jul 24, 2026 | 60d | $44.25 | $42.60 | -3.7% | -5.2% | +1.5% | +4.2% | — | $44.92 | 181 | $7.7K | −$298 | — | — | 7,027 | $311K | +13.8% | — | BOSTON SCIENTIFIC CORP | — | Health Care | textlayer · 80% |
| ||||||||||||||||||||||||||||
| Sep 22, 2026 |
|
not ahead | BSX | Sell | $1K–$15K | Jul 08, 2026 | 76d | $44.81 | $42.60 | -4.9% | -5.2% | +0.2% | +3.3% | — | $44.92 | 179 | $7.6K | $395 | — | — | 0 | — | — | — | BOSTON SCIENTIFIC CORP | — | Health Care | textlayer · 80% |
| ||||||||||||||||||||||||||||